Correlation Between Cumberland Pharmaceuticals and Incannex Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Incannex Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Incannex Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Incannex Healthcare Ltd, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Incannex Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Incannex Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Incannex Healthcare.

Diversification Opportunities for Cumberland Pharmaceuticals and Incannex Healthcare

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cumberland and Incannex is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Incannex Healthcare Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incannex Healthcare and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Incannex Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incannex Healthcare has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Incannex Healthcare go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Incannex Healthcare

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 0.97 times more return on investment than Incannex Healthcare. However, Cumberland Pharmaceuticals is 1.04 times less risky than Incannex Healthcare. It trades about 0.12 of its potential returns per unit of risk. Incannex Healthcare Ltd is currently generating about 0.0 per unit of risk. If you would invest  235.00  in Cumberland Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of  24.34  from holding Cumberland Pharmaceuticals or generate 10.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  Incannex Healthcare Ltd

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Incannex Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Incannex Healthcare Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Cumberland Pharmaceuticals and Incannex Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and Incannex Healthcare

The main advantage of trading using opposite Cumberland Pharmaceuticals and Incannex Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Incannex Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incannex Healthcare will offset losses from the drop in Incannex Healthcare's long position.
The idea behind Cumberland Pharmaceuticals and Incannex Healthcare Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance